(AP) -- Federal health officials have proposed a plan that would speed up the approval of innovative medical devices that hold the potential to dramatically improve patients' lives.
Faster approval times for generic drugs will get them into consumers' hands quicker, but may not make the price any better, a pricing and marketing researcher has found.
A warning issued by the Food and Drug Administration regarding the use of atypical antipsychotics for the treatment of dementia was associated with a significant decline in the use of these medications for treating dementia ...
(AP) -- GlaxoSmithKline says it has updated the labeling of its diabetes pill Avandia to include safety restrictions ordered by federal health authorities because of the drug's links to heart attack.
Winter is not good to our skin. The wind chaps. The dry air wicks. The combination blows us into the arms of the billion-dollar cosmeceutical industry, which awaits with pricey over-the-counter potions and serums promising ...
(PhysOrg.com) -- A first-line treatment for relapsing forms of multiple sclerosis (MS) was approved in September 2010 by the US Food and Drug Administration: FTY720 (fingolimod, Gilenya), which acts as a sphingosine 1-phosphate ...
(AP) -- Orexigen Therapeutics Inc. shares plunged nearly 75 percent in pre-market trading Tuesday after U.S. health officials declined to approve the experimental weight loss pill Contrave.
(PhysOrg.com) -- Many cochlear implant users may soon be able to easily modify the settings on their hearing devices using a smartphone interface, selecting one setting for a bustling restaurant, another for a hushed library.
(AP) -- Federal health officials said Wednesday they are investigating a possible link between breast implants and a very rare form of cancer after reviewing a handful of cases reported over the last 13 years.
(AP) -- The makers of Plavix, the world's second best-selling medication, said Tuesday they will retain exclusive U.S. marketing rights to the blood thinner for an additional six months, under a decision by U.S. health regulators.